Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.1200 (-8.98%) ($5.1200 - $5.1200) on Fri. Mar. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.8% (three month average) | RSI | 31 | Latest Price | $5.1200(-8.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -8.3% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) URA(74%) XME(76%) EEM(73%) VWO(68%) KWEB(63%) | Factors Impacting CAPR price | CAPR will decline at least -3.9% in a week (0% probabilities). OIH(-35%) USO(-26%) PEJ(-22%) VXX(-36%) UNG(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.9% (StdDev 7.8%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.11(-473.24%) | Resistance Level | $6.11 | 5 Day Moving Average | $5.35(-4.3%) | 10 Day Moving Average | $5.45(-6.06%) | 20 Day Moving Average | $6.11(-16.2%) | To recent high | -35.5% | To recent low | 0.4% | Market Cap | $101m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |